$1.77
-0.02 (-1.12%)
Open$1.81
Previous Close$1.79
Day High$1.82
Day Low$1.73
52W High$6.24
52W Low$1.30
Volume—
Avg Volume85.2K
Market Cap9.44M
P/E Ratio—
EPS$-3.65
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,365.5% upside
Current
$1.77
$1.77
Target
$43.64
$43.64
$27.68
$43.64 avg
$53.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.52M | 9.96M | 1.47M |
| Net Income | -48,346,397 | -29,857,789 | 533.2K |
| Profit Margin | -333.0% | -316.4% | 36.3% |
| EBITDA | -47,619,019 | -31,042,385 | 838.1K |
| Free Cash Flow | — | — | 521.2K |
| Rev Growth | +45.7% | +45.7% | +11.3% |
| Debt/Equity | 0.10 | 0.10 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |